imm-6-415
·Code: IMM-6-415
imm-6-415: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Immuneering Corp (IMRX) | Phase 1/Phase 2 |
Clinical Trials (1)
A Phase 1/2a Study of IMM-6-415 in Participants With Advanced or Metastatic Malignancies Harboring RAS or RAF Oncogenic Mutations
Frequently asked questions
Who is developing imm-6-415?
imm-6-415 is being developed by Immuneering Corp.
How many clinical trials involve imm-6-415?
BioSniper tracks 1 clinical trial involving imm-6-415.
Get deeper analysis on imm-6-415
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis